Perceptive LIFE Sciences Master FUND Ltd., Director at Astria Therapeutics, Inc. (ATXS), bought 2,149,216 shares at $6.51 ($14.0M) on 2023-10-16, disclosed to the SEC on 2023-10-18.
Open-market purchase of $14.0M ATXS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.51 | 460,546 | $3.0M | 21.4% |
| 2 | $6.51 | 460,546 | $3.0M | 21.4% |
| 3 | $6.51 | 614,062 | $4.0M | 28.6% |
| 4 | $6.51 | 614,062 | $4.0M | 28.6% |
| Total | $6.51 avg | 2,149,216 | $14.0M | 100% |
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |